This website is intended for use by residents of Sweden only

About Isofol

Isofol Medical AB (publ) is a biotech company that was founded in 2008 and is developing a new drug candidate for the treatment of advanced colorectal cancer. Colorectal cancer (CRC) is the third most common form of cancer worldwide and the need for more effective drugs to treat this disease is very high.


Upcoming Events


Stay updated on the latest news by
following Isofol on Linkedin.

LinkedIn logotype
Scroll to Top